STOCK TITAN

Nasdaq Halts Charming Medical Limited

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Nasdaq (Nasdaq: NDAQ) announced a trading halt in Charming Medical Limited (Nasdaq: MCTA) while Nasdaq requests additional information from the company.

The Securities and Exchange Commission previously suspended trading in MCTA from 04:00:00 on November 12, 2025 to 23:59:00 on November 25, 2025. The company\'s last reported sale price was $29.355. Trading will remain halted until Charming Medical Limited fully satisfies Nasdaq\'s information request. The SEC order is available at the SEC website linked in the announcement.

Loading...
Loading translation...

Positive

  • SEC trading suspension ended on Nov 25, 2025
  • Last reported share price was $29.355

Negative

  • Nasdaq trading halt remains in effect pending additional information
  • Prior SEC suspension covered Nov 12, 2025 to Nov 25, 2025

News Market Reaction – NDAQ

+0.94%
1 alert
+0.94% News Effect

On the day this news was published, NDAQ gained 0.94%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

MCTA last sale price: $29.355 SEC suspension start: 04:00:00 on November 12, 2025 SEC suspension end: 23:59:00 on November 25, 2025 +5 more
8 metrics
MCTA last sale price $29.355 Last reported sale price before SEC suspension window
SEC suspension start 04:00:00 on November 12, 2025 Start of SEC trading suspension in MCTA
SEC suspension end 23:59:00 on November 25, 2025 End of SEC trading suspension in MCTA
NDAQ pre-news price $93.85 NDAQ price before Nasdaq’s halt announcement on MCTA
NDAQ 52-week high $97.63 Pre-news 52-week high level
NDAQ 52-week low $64.84 Pre-news 52-week low level
Shares registered S-8 7,500,000 shares Additional NDAQ common shares for equity incentive plan (Form S-8)
Q3 2025 revenue $1.958 billion NDAQ revenues for Q3 2025 from Form 10-Q

Market Reality Check

Price: $85.15 Vol: Volume 5,495,971 is 1.83x...
high vol
$85.15 Last Close
Volume Volume 5,495,971 is 1.83x the 20-day average of 2,996,323 shares before this news. high
Technical Shares traded above the 200-day MA of $85.62 at a pre-news price of $93.85.

Peers on Argus

Before this halt notice, NDAQ was up 1.32% with peers also positive: MSCI +1.95%...

Before this halt notice, NDAQ was up 1.32% with peers also positive: MSCI +1.95%, ICE +1.21%, COIN +0.79%, MCO +0.62%, CME +1.89%. No momentum scanner signals suggested a coordinated sector move.

Historical Context

5 past events · Latest: Dec 09 (Neutral)
Pattern 5 events
Date Event Sentiment Move Catalyst
Dec 09 Short interest update Neutral +1.3% Report of end-of-month open short interest across all Nasdaq securities.
Dec 09 Listing transfer Neutral +1.0% Walmart common stock and bonds begin trading on Nasdaq after transfer.
Dec 03 Volume report Neutral +2.2% Release of November 2025 trading volumes and detailed statistics data sheet.
Dec 03 Investor conference Neutral +2.2% Announcement of presentation at Goldman Sachs 2025 Financial Services Conference.
Dec 02 Trading halt notice Neutral -0.9% Nasdaq halts MaxsMaking Inc. (MAMK) pending additional requested information.
Pattern Detected

Recent NDAQ headlines have been largely operational (volumes, listings, halts) with modest single-day price moves following announcements.

Recent Company History

Over recent months, NDAQ releases have focused on market statistics, listings, conferences, and trading halts in specific issuers. A short interest report on Nov 28, 2025 settlement data and November volume statistics coincided with modest gains of 1.32% and 2.19%. Nasdaq also highlighted Walmart’s transfer to its exchange and a planned Goldman Sachs conference appearance. Another trading halt, for MaxsMaking Inc. (MAMK), saw NDAQ move -0.95%, underscoring that such halt notices have not produced outsized reactions in NDAQ shares.

Market Pulse Summary

This announcement details Nasdaq’s decision to halt trading in Charming Medical Limited (MCTA) after...
Analysis

This announcement details Nasdaq’s decision to halt trading in Charming Medical Limited (MCTA) after an SEC trading suspension from November 12–25, 2025, with the last reported MCTA sale at $29.355. Nasdaq states trading will remain halted until requested information is fully provided. For NDAQ, this fits a stream of operational updates, including prior halt notices and volume statistics. Investors may watch for any follow-up disclosures from MCTA or the SEC to understand the underlying issues.

Key Terms

trading is halted, trading suspension
2 terms
trading is halted financial
"announced that trading is halted in Charming Medical Limited"
A trading halt is a temporary pause in buying and selling a company's stock on an exchange, put in place by the exchange or regulators when there is important news, extreme price movement, or uncertainty. It matters to investors because it prevents chaotic, one-sided trading and gives the market time to absorb new information; think of it as a pause button that stops action so everyone can catch up, but during the halt you cannot buy or sell the shares.
trading suspension regulatory
"the Securities and Exchange Commission effected a trading suspension in MCTA"
A trading suspension is a temporary halt on buying and selling a company's stock imposed by an exchange or regulator while a specific issue is resolved or more information is provided. It matters to investors because it freezes the market value and prevents trades—like pausing a game until the referee clears a disputed play—so investors cannot adjust positions and may face sudden price moves or uncertainty when trading resumes.

AI-generated analysis. Not financial advice.

NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) --  The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading is halted in Charming Medical Limited (Nasdaq: MCTA) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading suspension in MCTA from 04:00:00 on November 12, 2025 to 23:59:00 on November 25, 2025. The last sale price of the company’s ordinary shares was $29.355

More information about the SEC’s order can be found at https://www.sec.gov/files/litigation/suspensions/2025/34-104176.pdf.

Trading will remain halted until Charming Medical Limited has fully satisfied Nasdaq’s request for additional information.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

Nasdaq Contact:

Nasdaq MarketWatch
nasdaqmarketwatch@nasdaq.com

NDAQO


FAQ

Why did Nasdaq halt trading in Charming Medical Limited (MCTA) on November 26, 2025?

Nasdaq halted trading while it requests additional information from Charming Medical Limited; the halt remains until Nasdaq\\'s request is fully satisfied.

When did the SEC suspend trading in MCTA and for how long?

The SEC suspended trading from 04:00:00 on November 12, 2025 to 23:59:00 on November 25, 2025.

What was Charming Medical Limited\\'s last reported share price before the halt?

The last reported sale price was $29.355.

How can investors get more information about MCTA while trading is halted?

Contact Charming Medical Limited directly or check the company\\'s symbol via InfoQuotes on the Nasdaq website for updates.

Does the Nasdaq halt mean the SEC order is still in effect for MCTA?

The SEC suspension covered Nov 12–Nov 25, 2025; Nasdaq\\'s halt is a separate action that remains until Nasdaq\\'s information request is satisfied.
Nasdaq Inc

NASDAQ:NDAQ

View NDAQ Stock Overview

NDAQ Rankings

NDAQ Latest News

NDAQ Latest SEC Filings

NDAQ Stock Data

48.26B
448.19M
Financial Data & Stock Exchanges
Security & Commodity Brokers, Dealers, Exchanges & Services
Link
United States
NEW YORK